Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | AHR | P35869 | 3/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.39 |
| ▸ | PGR | P06401 | 3/20 | 0.36 |
| ▸ | PRKDC | P78527 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23441898 | 0.86 | AHR (0.41) | ALOX5AHRPDK2PGRPRKDC | |
| SCHEMBL12324541 | 0.86 | ALOX5 (0.57) | ALOX5AHRPDK2PGRPRKDC | |
| SCHEMBL16017825 | 0.85 | ALOX5 (0.56) | ALOX5AHRPDK2PGRPRKDC | |
| SCHEMBL24286990 | 0.84 | PDK2 (0.37) | AHRPDK2PGRMEN1KMT2A | |
| SCHEMBL21037803 | 0.84 | ALOX5 (0.49) | ALOX5AHRPDK2PGRPRKDC | |
| SCHEMBL1636918 | 0.84 | ALOX5 (0.47) | ALOX5PDK2PRKDCGGPS1PTGES2 | |
| SCHEMBL20276869 | 0.83 | ALOX5 (0.59) | ALOX5AHRPGRPRKDCGGPS1 | |
| SCHEMBL18086150 | 0.83 | ALOX5 (0.53) | ALOX5PDK2PRKDCGGPS1MEN1 | |
| SCHEMBL1637350 | 0.83 | ALOX5 (0.46) | ALOX5PDK2PRKDCGGPS1PTGES2 | |
| SCHEMBL18820381 | 0.82 | ALOX5 (0.39) | ALOX5PDK2PRKDCGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230015881-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE COMPOUND | GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230015881-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE COMPOUND | BRD9, MRPL9, INTS9 | ALOX5 1399/4885AHR 2577/4885PDK2 4112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.